All News #Library
Others
Harbour Biomed Appoints Dr. Adam Zong As President
16 Apr 2026 //
PR NEWSWIRE
Harbour Biomed Acquires Common Stock In Spruce Biosciences
18 Jan 2026 //
PR NEWSWIRE
Harbour BioMed Signs Antibody Deal with Bristol Myers Squibb
16 Dec 2025 //
PR NEWSWIRE
Harbour Biomed, Astrazeneca Collaborate On Oncology
23 Nov 2025 //
PR NEWSWIRE
Harbour BioMed Reports 2025 Interim Results
27 Aug 2025 //
PR NEWSWIRE
Harbour BioMed Appoints Yajie Li as Chief Medical Officer
25 Aug 2025 //
PR NEWSWIRE
Harbour Biomed Reports Positive Profit for 2025 Interim Results
28 Jul 2025 //
PR NEWSWIRE
Harbour BioMed Names Youchen Chen as Chief Financial Officer
10 Apr 2025 //
CONTRACTPHARMA
AstraZeneca investing $2.5 B in China
22 Mar 2025 //
REUTERS
Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal
10 Mar 2025 //
PR NEWSWIRE
Harbour BioMed Names Michael D. Patten Chief Strategy Officer
10 Mar 2025 //
PR NEWSWIRE
Harbour BioMed Announces Business Progress and Update
13 Feb 2025 //
PR NEWSWIRE
Harbour Gets NMPA IND Clearance for HBM9378 in COPD Treatment
04 Feb 2025 //
PR NEWSWIRE
Harbour BioMed Appoints Dr. Raymond as Chief Business Officer
14 Nov 2024 //
PR NEWSWIRE
Harbour BioMed Submits IND for HBM9378 in COPD Treatment
08 Nov 2024 //
PR NEWSWIRE
Harbour BioMed Announces 2024 Interim Results
28 Aug 2024 //
PR NEWSWIRE
Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results
18 Jul 2024 //
PR NEWSWIRE
Harbour BioMed Reports Full Year 2023 Financial Results
28 Mar 2024 //
PR NEWSWIRE
Harbour BioMed Announces Positive Profit Alert
18 Jan 2024 //
PR NEWSWIRE
Harbour BioMed Announces 2023 Interim Results
28 Aug 2023 //
PR NEWSWIRE
Harbour Appoints Dr. Albert R. Collinson as Independent Non-Executive Director
08 Aug 2023 //
PR NEWSWIRE
Harbour BioMed Announces 2023 Interim Results Positive Profit Alert
13 Jul 2023 //
PR NEWSWIRE

Market Place
Sourcing Support